Login / Signup

Segmental facial infantile haemangiomas in the era of propranolol: evaluation at 6 years of age.

O LetertreOlivia BoccaraSorilla PreyJ-M PedespanF BoraleviC Léauté-Labrèze
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
In this case series, children with SFIH, including patients with PHACES criteria, presented a good tolerance of propranolol, as well as encouraged neurodevelopmental data. Segmental implication appears to have a significant impact on treatment duration and associated complications.
Keyphrases
  • young adults
  • electronic health record
  • combination therapy
  • congenital heart disease
  • deep learning
  • replacement therapy
  • data analysis